DPC News

FDA to redo key compounding pharmacy policy in win for industry | Reuters

By Nate Raymond | February 23, 20225:08 PM EST

(Reuters) – The U.S. Food and Drug Administration is suspending a memorandum of understanding (MOU) with states governing how compounding pharmacies’ drugs are sold interstate and will engage in a years-long rulemaking process to adopt a new one.


SOURCE: https://www.reuters.com/legal/litigation/fda-redo-key-compounding-pharmacy-policy-win-industry-2022-02-23/

Categories: DPC News

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s